Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (271-280 of 686) with videos related to

Pageof 69
Sort By:
The Lancet. Oncology|November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
Cancer|September 14, 2011
Earlier age of onset of BRCA mutation-related cancers in subsequent generationsJennifer K Litton, Kaylene Ready, Huiqin Chen, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Scientific Reports|December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancerReham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 22, 2010
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomyMin Yi, Kelly K Hunt, Banu K Arun, et al.
Clinical Breast Cancer|July 19, 2011
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtypeRachel L Theriault, Jennifer K Litton, Elizabeth A Mittendorf, et al.
Annals of Surgical Oncology|September 26, 2008
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patientsElizabeth A Mittendorf, Aysegul A Sahin, Susan L Tucker, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Pageof 69

Showing results (271-280 of 686) with videos related to

Sort By:
Pageof 69
The Lancet. Oncology|November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
Cancer|September 14, 2011
Earlier age of onset of BRCA mutation-related cancers in subsequent generationsJennifer K Litton, Kaylene Ready, Huiqin Chen, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Scientific Reports|December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancerReham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 22, 2010
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomyMin Yi, Kelly K Hunt, Banu K Arun, et al.
Clinical Breast Cancer|July 19, 2011
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtypeRachel L Theriault, Jennifer K Litton, Elizabeth A Mittendorf, et al.
Annals of Surgical Oncology|September 26, 2008
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patientsElizabeth A Mittendorf, Aysegul A Sahin, Susan L Tucker, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Pageof 69